PACTR201508001190111尚未招募未知
In patients with hepatobiliary cancer, does unilateral splanchnic block is equally effective as bilateral splanchnic bock in reduction of cancer pain ?
diab fuad hetta0 个研究点目标入组 50 人开始时间: 2015年7月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Year(s) 至 90 Year(s)（—）
- 性别
- All
入选标准
- •patients with hepatobiliary cancer
排除标准
- •coagulopathy
- •infection at site of injection
- •allergy to study drugs
研究者
相似试验
已完成
2 期
Pilot study of nab-Paclitaxel in combination with capecitabine as second line treatment of advanced biliary cancer.advanced biliary cancerCancer - Biliary tree (gall bladder and bile duct)ACTRN12615000504516Illawarra and Shoalhaven Local Health District10
招募中
不适用
Sequential therapy for hepatocellular carcinoma -Real world evidence of TKI in prospective observational studyhepatocellular carcinomaJPRN-UMIN000038867Kyushu Study group of Clinical Cancer500
Enrolling By Invitation
不适用
Comparison between using hepatocellular carcinoma (HCC) risk scores and current criteria to identify chronic hepatitis B patients needing HCC surveillance-Compare between the use of HCC risk scores and current criteria to identify HCC high risk in chronic hepatitis B patients -Role the HCC risk scores to identify HCC high risk in chronic hepatitis BTCTR20200827002one201
进行中（未招募）
3 期
Hepatocellular Carcinoma Surveillance in Patients with Chronic Hepatitis B Infection: A cohort StudyHepatocelluar carcinomaChronic Hepatitis BUltrasoundSurveillanceHepatocellular carcinomaTCTR20160124001Chulabhorn Hospital2,200
已完成
不适用
Prognosis of patient with hepatocellular carcinoma in chronic hepaitits C.Hepatitis CJPRN-C000000227Ikeda Municipal Hospital100